TPG inks $1.9bn pharma take-private(2)
The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination